Establishing an islet transplantation program in a developing country

Transplant Proc. 2004 Jul-Aug;36(6):1700-3. doi: 10.1016/j.transproceed.2004.06.016.

Abstract

Diabetes is an emerging epidemic throughout the world. In our city alone, there are approximately 25,000 known diabetics (5% to 10% type 1) among a total population of 1.7 million inhabitants, and the incidence is increasing among all age groups. Islet transplantation is a potential treatment for type 1 diabetes mellitus. For this reason, we intended to establish an islet transplantation program. This required competent and well-trained professionals, a specially planned facility adhering to rigid regulations regarding safety and sterility, and a detailed study of the ethical laws and rules involving transplantation. In this article, we describe the process including any difficulties or barriers encountered due to limited resources in a developing country. We also describe all stages of personnel training and the necessary equipment and work area of a similar specialized center following the guidelines of the Brazilian National Agency for Health Care. Finally, we discuss our expectations for the initial phase of our islet transplantation program.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brazil
  • Costs and Cost Analysis
  • Developing Countries
  • Humans
  • Islets of Langerhans Transplantation / economics
  • Islets of Langerhans Transplantation / statistics & numerical data*
  • Tissue and Organ Procurement / organization & administration
  • United States